Racial and Ethnic Representation in Clinical Trials of Janus Kinase Inhibitors for Dermatologic Conditions: A Systematic Review
Journal of Drugs in Dermatology · 01.04.2026 · 25 (4) · 316-323
DOI: 10.36849/jdd.9441 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.03.2026. Verfasst von Christine Olagun-Samuel und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Janus Kinase Inhibitors, Skin Diseases, Clinical Trials as Topic, Ethnicity.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Olagun-Samuel, C., Ansah, M. A., Shakelly, P., Sherali, N., Ologunebi, A., Sicco, K. L., & Adotama, P. (2026). Racial and Ethnic Representation in Clinical Trials of Janus Kinase Inhibitors for Dermatologic Conditions: A Systematic Review. Journal of Drugs in Dermatology, 25(4), 316-323. https://doi.org/10.36849/jdd.9441
Vancouver
Olagun-Samuel C, Ansah MA, Shakelly P, Sherali N, Ologunebi A, Sicco KL, et al. Racial and Ethnic Representation in Clinical Trials of Janus Kinase Inhibitors for Dermatologic Conditions: A Systematic Review. Journal of Drugs in Dermatology. 2026;25(4):316-323. doi:10.36849/jdd.9441
BibTeX
@article{OlagunSamuel2026,
author = {Olagun-Samuel, Christine and Ansah, Maame-Afua and Shakelly, Purvi and Sherali, Nabiha and Ologunebi, Aminat and Sicco, Kristen Lo and Adotama, Prince},
title = {Racial and Ethnic Representation in Clinical Trials of Janus Kinase Inhibitors for Dermatologic Conditions: A Systematic Review},
journal = {Journal of Drugs in Dermatology},
year = {2026},
volume = {25},
number = {4},
pages = {316--323},
doi = {10.36849/jdd.9441}
}
EUVIMED